Barriers to HIV vaccine response explored

This finding could complicate the development of HIV vaccines designed to elicit this protective antibody, called 4E10, and others like it, as doing so might be dangerous or inefficient.

http://www.sciencedaily.com/releases/2013/09/130920094221.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fvaccines+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Vaccines%29